What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Annual Revenue?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Annual Revenue rose 97.25%, in the last year to $0.16 M. Its sector's average revenue growth for the last fiscal year was 3.57%.

What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Annual Net Profit?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Annual Net Profit rose 2.74% in the last year to $6.73 M. Its sector's average net profit growth for the last fiscal year was 10.5%.

What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Stock Price?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Stock Price fell 16.95% and underperformed its sector by 40.87% in the past year.

What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Debt to Equity Ratio?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Return on Equity(ROE)?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -92.92%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Mutual Fund Holding?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Mutual Fund Holding remained the same in the last quarter at 0.01%.

What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Interest Coverage Ratio?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Interest Coverage Ratio is -249.73, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Virax Biolabs Group Ltd - Ordinary Shares - Class A Institutional Holding?

Virax Biolabs Group Ltd - Ordinary Shares - Class A Institutional Holding decreased by 0.27% in the last quarter to 1.18.

Virax Biolabs Group Ltd - Ordinary Shares - Class A XNAS: VRAX

Virax Biolabs Group Ltd - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Virax Biolabs Group Ltd - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Virax Biolabs Group Ltd - Ordinary Shares - Class A
Rating: 0.78600
Author: Trendlyne DVM scores

about

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprieta...

0.98 0.02 (2.08%)

89.11% Fall from 52W High

46,995 XNAS Volume

XNAS 02 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

16.0 / 100

Technically Bearish

15.4 / 100

3

1Yr Price target upside is 206%

1 analysts

Virax Biolabs Group Ltd - ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Virax Biolabs Group Ltd - Ordinary Shares - Class A FAQ

How is Virax Biolabs Group Ltd - Ordinary Shares - Class A today?

Virax Biolabs Group Ltd - Ordinary Shares - Class A today is trading in the green, and is up by 2.08% at 0.98.

How has Virax Biolabs Group Ltd - Ordinary Shares - Class A performed historically?

Virax Biolabs Group Ltd - Ordinary Shares - Class A is currently trading up 2.08% on an intraday basis. In the past week the stock fell -3.92%. stock has been down -41.32% in the past quarter and fell -16.95% in the past year. You can view this in the overview section.